Pretreatment levels of serum lactate dehydrogenase (LDH) and clinical outcome in metastatic colorectal cancer patients receiving first-line chemotherapy and bevacizumab.

被引：0
|
作者：
Maccaroni, Elena
Giampieri, Riccardo
Scartozzi, Mario
Del Prete, Michela
Faloppi, Luca
Bianconi, Maristella
Bittoni, Alessandro
Galizia, Eva
Loretelli, Cristian
Belvederesi, Laura
Cascinu, Stefano
机构：
[1] Univ Politecn Marche, Scuola Specializzaz Oncol Med, Ancona, Italy
[2] AO Osped Riuniti Univ Politecn Marche, Ancona, Italy
[3] AO Osped Riuniti Univ Politecn Marche, Clin Oncol Med, Ancona, Italy
[4] Univ Politecn Marche, Scuola Specializzaz Oncol, Ancona, Italy
[5] Osped Profili, Oncol Med, Fabriano, Italy
[6] AO Osped Riuniti Univ Politecn Marche, Ctr Reg Genet Oncol, Ancona, Italy
[7] Univ Politecn Marche, Ctr Reg Genet Oncol, Ancona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.
    Demircan, Nazim
    Dane, Faysal
    Ozturk, Mehmet Akif
    Besiroglu, Mehmet
    Babacan, Nalan
    Kaya, Serap
    Ercelep, Ozlem
    Simsek, Eda Tanrikulu
    Halil, Suleyman
    Koca, Sinan
    Alan, Ozkan
    Hasanov, Rahib
    Yumuk, Perran Fulden
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy
    Roselli, Mario
    Formica, Vincenzo
    Cereda, Vittore
    Jochems, Caroline
    Richards, Jacob
    Grenga, Italia
    Orlandi, Augusto
    Ferroni, Patrizia
    Guadagni, Fiorella
    Schlom, Jeffrey
    ONCOIMMUNOLOGY, 2016, 5 (07):
  • [23] Bevacizumab with chemotherapy for the first-line treatment of metastatic colorectal cancer: "NCI Slovakia" results
    Dolinsky, J.
    Salek, T.
    Hlavata, Z.
    Ivancova, H.
    Risnyovszka, Z.
    Mardiak, J.
    Koza, I
    ANNALS OF ONCOLOGY, 2006, 17 : 70 - 70
  • [24] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study
    Diaz-Rubio, Eduardo
    Gomez-Espana, Auxiliadora
    Massuti, Bartomeu
    Sastre, Javier
    Reboredo, Margarita
    Luis Manzano, Jose
    Rivera, Fernando
    Jose Safont, Ma
    Montagut, Clara
    Gonzalez, Encarnacion
    Benavides, Manuel
    Marcuello, Eugenio
    Cervantes, Andres
    Martinez de Prado, Purificacion
    Fernandez-Martos, Carlos
    Arrivi, Antonio
    Bando, Inmaculada
    Aranda, Enrique
    PLOS ONE, 2012, 7 (10):
  • [26] Exploration of clinical determinants in prescribing oral capecitabine in patients receiving first-line chemotherapy for metastatic colorectal cancer (MCRC)
    Joosens, Eric
    Kalantari, Hassan Rezaei
    ACTA CLINICA BELGICA, 2008, 63 (01): : 53 - 53
  • [27] ARTERIAL HYPERTENSION CORRELATES WITH CLINICAL OUTCOME IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST-LINE BEVACIZUMAB
    Scartozzi, M.
    Galizia, E.
    Giampieri, R.
    Chiorrini, S.
    Berardi, R.
    Pierantoni, C.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 128 - 129
  • [28] Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
    Scartozzi, M.
    Galizia, E.
    Chiorrini, S.
    Giampieri, R.
    Berardi, R.
    Pierantoni, C.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 227 - 230
  • [29] Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
    Usakova, V.
    Sevcikova, K.
    Usak, J.
    Bartosova, Z.
    Mikulova, M.
    Spanik, S.
    NEOPLASMA, 2013, 60 (01) : 83 - 91
  • [30] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    British Journal of Cancer, 2010, 102 : 1468 - 1473
12345